Longboard Pharmaceuticals, Inc. (LBPH)

Longboard Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	27.61	14.33	10.78	66.35	55.32
Short-Term Investments	260.84	34.17	56.81	40.38	-
Cash & Short-Term Investments	288.45	48.5	67.59	106.73	55.32
Cash Growth	414.94%	-28.25%	-36.67%	92.94%	-
Prepaid Expenses	4.58	1.72	2.25	1.66	0.05
Total Current Assets	293.03	50.22	69.84	108.38	55.36
Property, Plant & Equipment	3.73	0.48	0.75	0.54	-
Long-Term Deferred Charges	-	-	-	-	0.88
Other Long-Term Assets	0.24	-	0.03	0.03	-
Total Assets	297.01	50.7	70.62	108.95	56.24
Accounts Payable	1.13	1	1.31	1.03	1.21
Accrued Expenses	16.92	8.26	7.06	3.91	1.92
Current Portion of Leases	0.27	0.48	0.36	0.34	-
Current Income Taxes Payable	0.03	0.04	0.03	0.17	-
Total Current Liabilities	18.35	9.77	8.76	5.44	3.14
Long-Term Leases	3.47	-	0.38	0.19	-
Total Liabilities	21.82	9.77	9.15	5.63	3.14
Common Stock	0	0	0	0	-
Additional Paid-In Capital	476.36	181.56	148.3	145.68	11.71
Retained Earnings	-201.88	-140.56	-86.14	-42.2	-14.4
Comprehensive Income & Other	0.7	-0.08	-0.69	-0.16	-
Total Common Equity	275.19	40.92	61.47	103.32	-2.69
Shareholders' Equity	275.19	40.92	61.47	103.32	53.1
Total Liabilities & Equity	297.01	50.7	70.62	108.95	56.24
Total Debt	3.73	0.48	0.74	0.52	-
Net Cash (Debt)	284.71	48.02	66.85	106.2	55.32
Net Cash Growth	412.87%	-28.16%	-37.05%	91.99%	-
Net Cash Per Share	8.30	2.11	3.90	7.37	14.52
Filing Date Shares Outstanding	39.05	36.02	22.97	17.22	3.84
Total Common Shares Outstanding	39.03	24.52	17.22	17.22	3.84
Working Capital	274.68	40.45	61.07	102.94	52.23
Book Value Per Share	7.05	1.67	3.57	6.00	-0.70
Tangible Book Value	275.19	40.92	61.47	103.32	-2.69
Tangible Book Value Per Share	7.05	1.67	3.57	6.00	-0.70

Source: S&P Capital IQ. Standard template. Financial Sources.